SCHEMBL24819258

SCHEMBL24819258

Cc1ccc(C)n1-c1cc(Cl)c(Oc2ccc(=O)n(Cc3ccc(OC(F)(F)F)cc3)c2)c(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 2/20 0.39
▸ MCHR1 Q99705 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ TSHR P16473 1/20 0.38
▸ PPARD Q03181 3/20 0.37
▸ PPARA Q07869 3/20 0.37
▸ TYMS P04818 1/20 0.37
▸ HCRTR1 O43613 3/20 0.36
▸ HCRTR2 O43614 3/20 0.36
▸ CHRM5 P08912 3/20 0.36
▸ PPARG P37231 1/20 0.36
▸ P2RX7 Q99572 2/20 0.36
▸ HTR2C P28335 1/20 0.35
▸ SDHB P21912 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ GRM2 Q14416 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23168941 0.89 THRB (0.38) NPBWR1ALDH1A1P2RX7POLB
SCHEMBL23168772 0.88 MAPT (0.43) NPBWR1MCHR1ALDH1A1P2RX7POLB
SCHEMBL23168932 0.87 NPBWR1 (0.43) NPBWR1MCHR1ALDH1A1SDHB
SCHEMBL23168748 0.86 P2RX7 (0.37) NPBWR1ALDH1A1P2RX7SDHBPOLB
SCHEMBL29822173 0.86 P2RX7 (0.40) ALDH1A1P2RX7POLB
SCHEMBL23168950 0.86 P2RX7 (0.40) ALDH1A1P2RX7POLB
SCHEMBL24819271 0.84 NPBWR1 (0.48) NPBWR1MCHR1P2RX7L3MBTL1
SCHEMBL29821988 0.84 NPBWR1 (0.48) NPBWR1MCHR1P2RX7L3MBTL1
SCHEMBL23168745 0.84 KLKB1 (0.40) NPBWR1MCHR1ALDH1A1TSHRPPARD
SCHEMBL23168653 0.81 MAPT (0.47) NPBWR1MCHR1CHRM5P2RX7SDHB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2026-05-05 — — US disclosed
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed
EP-4036090-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2022-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF THRB, TSHR, THRA NPBWR1 336/4885MCHR1 251/4885ALDH1A1 1134/4885
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof THRB, TSHR, THRA NPBWR1 267/4885MCHR1 223/4885ALDH1A1 1340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback